Data / Form D filings / SEN-JAM PHARMACEUTICAL INC.
SEN-JAM PHARMACEUTICAL INC.: Form D filings
SEN-JAM PHARMACEUTICAL INC., a pharmaceuticals company in Huntington, NY, filed 4 Form D notices with the SEC between 2020 and 2024. The latest, on July 25, 2024, reports $295,000 sold of a $10 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 223 WALL STREET, #130, Huntington, NY, 11743
- Phone
- (201) 400-8083
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1802249
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 25, 2024 | Amendment | $10,000,000 | $295,000 | $9,705,000 | 6 | Apr 22, 2023 | sec.gov |
| Jul 12, 2023 | New notice | $10,000,000 | $80,000 | $9,920,000 | 2 | Apr 22, 2023 | sec.gov |
| Jun 2, 2020 | Amendment | $3,240,000 | $185,000 | $3,055,000 | 5 | Jan 28, 2020 | sec.gov |
| Feb 5, 2020 | New notice | $3,000,000 | $0 | $3,000,000 | 2 | Jan 28, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jacqueline Iversen | Executive Officer | |
| James Iversen | Director, Executive Officer |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Jul 22, 2024 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SEN-JAM PHARMACEUTICAL INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.